| Product Name | MF | CAS | Details |
|---|
| Vandetanib | C22H24BrFN4O2 | 443913-73-3 | Details |
| Motesanib | C22H23N5O | 453562-69-1 | Details |
| Nintedanib Ethanesulfonate Salt | C33H39N5O7S | 656247-18-6 | Details |
| Masitinib mesylate | C29H34N6O4S2 | 1048007-93-7 | Details |
| Dasatinib hydrochloride | C22H27Cl2N7O2S | 854001-07-3 | Details |
| Multi-kinase inhibitor 1 | C20H17F3N4O3 | 778274-97-8 | Details |
| Mirk-IN-1 | C23H17Cl2N5O4 | 1386979-55-0 | Details |
| Orelabrutinib | C26H25N3O3 | 1655504-04-3 | Details |
| SU4312 | C17H16N2O | 5812-07-7 | Details |
| Pralsetinib | C27H32FN9O2 | 2097132-94-8 | Details |
| Acrizanib | C20H18F3N7O2 | 1229453-99-9 | Details |
| Lanraplenib succinate | C27H31N9O5 | 1800047-00-0 | Details |
| UNC2025 hydrochloride | C28H41ClN6O | 2070015-17-5 | Details |
| ENMD-2076 | C21H25N7 | 934353-76-1 | Details |
| Ibrutinib-biotin | C56H80N12O9S | 1599432-18-4 | Details |
| JH-VIII-157-02 | C28H27N5O2 | 1639422-97-1 | Details |
| SRI 31215 TFA | C27H34F3N5O3 | 1832686-44-8 | Details |
| Tyrphostin AG1433 | C16H14N2O2 | 168835-90-3 | Details |
| Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
| Cabozantinib S-malate | C32H30FN3O10 | 1140909-48-3 | Details |
| Ningetinib Tosylate | C38H37FN4O8S | 1394820-77-9 | Details |
| BMS-935177 | C31H26N4O3 | 1231889-53-4 | Details |
| JNJ-38877618 | C20H12F2N6 | 943540-74-7 | Details |
| TAS-115 mesylate | C28H27FN4O7S2 | 1688673-09-7 | Details |
| AZ-Dyrk1B-33 | C19H16N4 | 1679330-37-0 | Details |
| Jaspamycin | C12H12N4O5 | 22242-96-2 | Details |
| FGFR1/DDR2 inhibitor 1 | C28H22F3N5O | 2308497-58-5 | Details |
| SU14813 maleate | C23H27FN4O4.C4H4O4 | 849643-15-8 | Details |
| Vorolanib | C23H26FN5O3 | 1013920-15-4 | Details |
| tBID | C11H3Br4N3O2 | 1639895-85-4 | Details |
| AZD7507 | C23H27FN6O3 | 1041852-85-0 | Details |
| UNC2541 | C24H34FN7O2 | 1612782-86-1 | Details |
| Y15 | C6H11ClN4 | 4506-66-5 | Details |
| PF-573228 | C22H20F3N5O3S | 869288-64-2 | Details |
| Pazopanib Hydrochloride | C21H24ClN7O2S | 635702-64-6 | Details |
| SU16f | C24H22N2O3 | 251356-45-3 | Details |
| R406 | C28H29FN6O8S | 841290-81-1 | Details |
| Toceranib phosphate | C22H28FN4O6P | 874819-74-6 | Details |
| TG 100572 Hydrochloride | C26H27Cl2N5O2 | 867331-64-4 | Details |
| Brigatinib | C29H39ClN7O2P | 1197953-54-0 | Details |
| Btk inhibitor 2 | C24H25N5O3 | 1558036-85-3 | Details |
| ARQ 531 | C25 H23 Cl N4 O4 | 2095393-15-8 | Details |
| Rp-cAMPS sodium salt | C10H13N5NaO5PS | 142439-94-9 | Details |
| Vecabrutinib | C22H24ClF4N7O2 | 1510829-06-7 | Details |
| Remibrutinib | C27H27F2N5O3 | 1787294-07-8 | Details |
| BT-13 | C23H27F4N3O4S | 924537-98-4 | Details |
| cFMS Receptor Inhibitor II | C23H20N4O | 959860-85-6 | Details |
| Bozitinib | C20H15F3N8 | 1440964-89-5 | Details |
| WRG-28 | C21H18N2O5S | 1913291-02-7 | Details |
| Lyn-IN-1 | C30H31F3N8O | 887650-05-7 | Details |
| Lck inhibitor 2 | C18H17N5O2 | 944795-06-6 | Details |
| INDY | C12H13NO2S | 1169755-45-6 | Details |
| SKLB4771 | C25H27N7O3S2 | 1370256-78-2 | Details |
| Gilteritinib hemifumarate | C33H48N8O7 | 1254053-84-3 | Details |
| (±)-Zanubrutinib | C27H29N5O3 | 1633350-06-7 | Details |
| MAZ51 | C21H18N2O | 163655-37-6 | Details |
| RU-301 | C21H19F3N4O4S | 1110873-99-8 | Details |
| PDGFRα kinase inhibitor 1 | C34H34N8O2 | 2209053-93-8 | Details |
| SPP-86 | C16H15N5 | 1357349-91-7 | Details |
| AG 1295 | C16H14N2 | 71897-07-9 | Details |
| Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
| BMS-509744 | C32H41N5O4S2 | 439575-02-7 | Details |
| PF-06465469 | C30H33N7O2 | 1407966-77-1 | Details |
| CHMFL-BMX-078 | C33H35N7O6 | 1808288-51-8 | Details |
| TAK-659 hydrochloride | C17H22ClFN6O | 1952251-28-3 | Details |
| Ensartinib hydrochloride | C26H28Cl3FN6O3 | 2137030-98-7 | Details |
| PRN1008 | C36H40FN9O3 | 1575596-29-0 | Details |
| Bosutinib | C26H29Cl2N5O3 | 380843-75-4 | Details |
| Rp-cAMPS triethylammonium salt | C16H27N6O5PS | 151837-09-1 | Details |
| A-770041 | C34H39N9O3 | 869748-10-7 | Details |
| Lck Inhibitor | C31H30N8O | 847950-09-8 | Details |
| Tyrosine kinase inhibitor | C31H31FN6O5 | 1021950-26-4 | Details |
| Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
| Tirbanibulin Mesylate | C27H33N3O6S | 1080645-95-9 | Details |
| PRN694 | C28H35F2N5O2S | 1575818-46-0 | Details |
| TL02-59 | C32H34F3N5O4 | 1315330-17-6 | Details |
| FN-1501 | C22H25N9O | 1429515-59-2 | Details |
| AZD3229 Tosylate | C31H34FN7O6S | 2248003-71-4 | Details |
| CLK-IN-T3 | C28H30N6O2 | 2109805-56-1 | Details |
| CSF1R-IN-1 | C25H20F3N5O2 | 2095849-04-8 | Details |
| TAM-IN-2 | C31H27F2N7O3 | 2135642-56-5 | Details |
| BPR1K871 | C25H28ClN7O2S | 2443767-35-7 | Details |
| AGL-2263 | C17H10N2O5 | 638213-98-6 | Details |
| Syk-IN-1 | C18H22N8O | 1491150-77-6 | Details |
| Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
| DPH | C18H13FN4O2 | 484049-04-9 | Details |
| Dovitinib lactate | C24H27FN6O4 | 692737-80-7 | Details |
| KB SRC 4 | C32H23ClN8 | 1380088-03-8 | Details |
| Osteogenic Growth Peptide (10-14) | C24H29N5O7 | 105250-85-9 | Details |
| trans-Pralsetinib | C27H32FN9O2 | 2097132-93-7 | Details |
| Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
| Pivanex | C10H18O4 | 122110-53-6 | Details |
| Petunidin chloride | C16H13ClO7 | 1429-30-7 | Details |
| TIE-2/VEGFR-2 kinase-IN-1 | C13H11N3O2 | 453590-24-4 | Details |
| PF-04217903 methanesulfonate | C20H20N8O4S | 956906-93-7 | Details |
| Tirbanibulin dihydrochloride | C20H21ClN4O | 1038395-65-1 | Details |
| 3-Hydroxy Midostaurin | C35H30N4O5 | 179237-49-1 | Details |
| Conteltinib | C32H45N9O3S | 1384860-29-0 | Details |
| PD173074 | C28H41N7O3 | 219580-11-7 | Details |
| Sunitinib | C22H27FN4O2 | 557795-19-4 | Details |
| Product Total： Product Page： | ||||
| 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||